Sotera Health (SHC) Expected to Announce Earnings on Tuesday

Sotera Health (NASDAQ:SHC) is expected to be posting its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect the company to announce earnings of $0.24 per share and revenue of $300.68 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 9:00 AM ET.

Sotera Health Price Performance

NASDAQ:SHC opened at $17.49 on Monday. Sotera Health has a 52-week low of $9.53 and a 52-week high of $19.85. The company has a market cap of $4.97 billion, a P/E ratio of 92.06 and a beta of 1.82. The company has a debt-to-equity ratio of 4.04, a quick ratio of 2.18 and a current ratio of 2.38. The stock’s 50-day simple moving average is $17.97 and its 200 day simple moving average is $16.77.

Wall Street Analysts Forecast Growth

SHC has been the subject of a number of recent analyst reports. Wells Fargo & Company cut shares of Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. JPMorgan Chase & Co. upped their price objective on Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research note on Wednesday, November 5th. BMO Capital Markets assumed coverage on Sotera Health in a research note on Thursday, November 13th. They set an “outperform” rating and a $19.00 target price for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Finally, Zacks Research downgraded Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $20.00.

Insider Transactions at Sotera Health

In related news, CEO Michael B. Jr. Petras sold 434,104 shares of the business’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $16.45, for a total value of $7,141,010.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Pincus & Co. Warburg sold 9,720,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the sale, the director directly owned 34,102,952 shares of the company’s stock, valued at approximately $556,901,206.16. This trade represents a 22.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 17,384,104 shares of company stock valued at $284,024,511. 55.12% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Sotera Health

A number of institutional investors have recently modified their holdings of SHC. EverSource Wealth Advisors LLC grew its position in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Sotera Health by 736.5% during the 4th quarter. Wells Fargo & Company MN now owns 4,283 shares of the company’s stock valued at $76,000 after purchasing an additional 3,771 shares during the last quarter. Quadrant Capital Group LLC bought a new stake in shares of Sotera Health during the 3rd quarter valued at approximately $86,000. Los Angeles Capital Management LLC acquired a new position in Sotera Health during the 4th quarter worth approximately $90,000. Finally, PNC Financial Services Group Inc. lifted its stake in Sotera Health by 10.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock valued at $127,000 after purchasing an additional 705 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.